Nagoya City University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Nagoya City Japan (1884)

Organization Overview

First Clinical Trial
2010
NCT01179490
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Department of Anesthesiology, Nagoya City University | Nagoya City University Graduate School of Medical Sciences | Nagoya City Univsersity

Active Ingredients

Drugs in Phase 4 Trials (4)

bevacizumab (avastin) (1 trial)

mirtazapine (remeron) (1 trial)

ranibizumab (lucentis) (3 trials)

sertraline (zoloft) (1 trial)

Drugs in Phase 2 Trials (2)

bendamustine (treanda) (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Other Trials (1)

ringer's lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Edema (Phase 4)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Retinal Vein Occlusion (Phase 4)

Wet Macular Degeneration (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7